Penny stock MedMen (OTCMKTS: MMNFF) is up more than 40% in intraday trading today, one of a number of cannabis stocks surging after Democratic senators said they would make marijuana reform a legislative priority. Source: Shutterstock The surge in price comes on the back of heavy trade volume.
Full Answer
How much is a share of MedMen stock worth?
Cannabis company MedMen Enterprises Inc. on Wednesday announced a six month grace period for a $114.3 million commercial loan agreement issued on Oct. 1, 2018. MedMen CEO Michael Serruya said the ...
Why is MedMen up 40% in intraday trading today?
1 of their NY license’s worth is estimated to be $150million…the current market cap is $138Million…Medmen is incredibly undervalued. The stock price is …
Is MedMen Enterprises Inc (MMNFF) a good investment?
Feb 04, 2021 · Penny stock cannabis retailer MedMen is up more than 40% today over hopes of legalization in the U.S. and general sector bullishness.
What is the ticker symbol for MedMen Enterprises?
Will MedMen go out of business?
The company is still in business, though a shell of its former self. Canadian cannabis company Tilray bought up a chunk of its debt in August and MedMen has a new interim CEO in Michael Serruya, its third since Bierman was forced out in early 2020.Jan 24, 2022
Is there any hope for MedMen?
The key investor takeaway is that MedMen is still a major gamble. The MSO has more hope of surviving and thriving, but the stock has a lot more risk than other MSO stocks that are currently beaten down.Sep 26, 2021
Is MedMen a good stock to invest in?
1. MedMen. MedMen Enterprises ( MMNFF 0.66% ) ranked as the best-performing cannabis stock in February with its shares more than tripling in value. So far this year, the retail cannabis stock is up over 250%.Mar 2, 2021
What happened to MedMen?
MedMen went public on the Canadian Stock Exchange via a reverse takeover (RTO). The company listed under the stock ticker symbol MMEN on May 29, 2018. In June 2018, MedMen announced its acquisition of a nursery and retail license to build 25 stores in Florida.
Who is buying MedMen?
Under the deal announced last February, worth at least $63 million, Ascend would acquire an 86.7% interest in MedMen's New York cannabis business with an option to acquire the remainder after the launch of New York's adult-use marijuana market. New York-based Ascend announced Dec.Jan 3, 2022
How many shares of MedMen are there?
1.21BMedMen Enterprises Inc.Volume2.85MShares Outstanding1.21BEPS (TTM)-$0.1574P/E Ratio (TTM)N/ADividend YieldN/A7 more rows
Is MedMen a buy sell or hold?
The consensus rating for MedMen Enterprises is Hold while the average consensus rating for medical companies is Buy.
How much debt is MedMen?
MedMen ended the fiscal third quarter with $326 million in net debt. If you factor in the recently announced equity raise and $160 million in convertible debt, it leaves $87 million in net debt, according to Zuanic.Aug 18, 2021
Does Tilray own MedMen?
Tilray has a 68% interest in the SPV, giving it an economic interest of $112.7 million via the notes and 92.0 million warrants. This provides Tilray an approximate 21% ownership in MedMen.Aug 25, 2021
Is Tilray buying MedMen?
MedMen owns 26 dispensaries. Culver City-based cannabis retailer MedMen Enterprises Inc., which has struggled financially for several years, just received a lifeline.Aug 23, 2021
3.0 Analyst's Opinion
MedMen Enterprises has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.
Is MedMen Enterprises a buy right now?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedMen Enterprises in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MedMen Enterprises stock.
How has MedMen Enterprises' stock price been impacted by Coronavirus (COVID-19)?
MedMen Enterprises' stock was trading at $0.1539 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, MMNFF shares have decreased by 19.1% and is now trading at $0.1245. View which stocks have been most impacted by COVID-19.
How were MedMen Enterprises' earnings last quarter?
MedMen Enterprises Inc. (OTCMKTS:MMNFF) issued its quarterly earnings data on Monday, February, 15th. The company reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by $0.03. View MedMen Enterprises' earnings history.
What price target have analysts set for MMNFF?
1 equities research analysts have issued 12-month price targets for MedMen Enterprises' shares. Their forecasts range from $0.25 to $0.25. On average, they anticipate MedMen Enterprises' share price to reach $0.25 in the next twelve months.
Who are some of MedMen Enterprises' key competitors?
Some companies that are related to MedMen Enterprises include Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE), CannPal Animal Therapeutics (CP1), Cansortium (CNTMF), Chalice Brands (GLDFF) and Charlotte's Web (CWBHF). View all of MMNFF's competitors..
What is MedMen Enterprises' stock symbol?
MedMen Enterprises trades on the OTCMKTS under the ticker symbol "MMNFF."